Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer. (March 2019) - Lesch, S.; Blumenberg, V.; Stoiber, S.; Ogonek, J.; Cadilha, B.; Dantes, Z.; Rataj, F.; Dorman, K.; Lutz, J.; Karches, C.; Heise, C.; Grassmann, S.; et al.